106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2021 All rights reserved
AANASM08212a
Disclaimer
is pocket guide attempts to define principles of practice that should produce high-quality patient care.
It is applicable to specialists, primary care, and providers at all levels. is pocket guide should not
be considered exclusive of other methods of care reasonably directed at obtaining the same results. e
ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer
consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors
endorse any product or service associated with the distributor of this clinical reference tool.
Abbreviations
ASM, antiseizure medication
Source
Gloss D, Pargeon K, Pack A, et al. Practice advisory update summary: Antiseizure medication
withdrawal in seizure-free patients. Report of the Guideline Subcommittee of the AAN.
Neurology. 2021 December 6. doi:10.1212/WNL.0000000000012944
Classification of Management Recommendations
Classification Definition
Level (A) Denotes a practice recommendation that "must" be done. In almost all
circumstances, adherence to the recommendation will improve health-
related outcomes.
Level (B) Indicates a recommendation that "should" be done. In most circumstances,
adherence to the recommendation will likely improve health-related
outcomes.
Level (C) Represents a recommendation that "might" be done. In some
circumstances, adherence to the recommendation might improve health-
related outcomes.
Level (U) Indicates that the available evidence is insufficient to support or refute the
efficacy of an intervention.
Level (R) Assigned when the balance of benefits and harms is unknown and the
intervention is known to be expensive or have important risks. is level
designates that the intervention should not be used outside of a research
setting.
